Ascendis Pharma Gets Bullish Rating; Three Fresh Initiations on Thursday

Top Wall Street analysts adjusted their outlooks on these prominent companies. For a complete view of all analyst rating changes, visit our analyst ratings page.

HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Ascendis Pharma A/S with a Buy rating and announced a price target of $345. Ascendis Pharma closed Wednesday at $250.25. See how other analysts rate the stock.

Truist Securities analyst Miller Jump initiated coverage on DigitalOcean Holdings Inc with a Buy rating and announced a price target of $175. DigitalOcean shares closed Wednesday at $114.99. See how other analysts rate the stock.

HC Wainwright & Co. analyst Emily Bodnar initiated coverage on Odyssey Therapeutics, Inc. with a Buy rating and announced a price target of $44. Odyssey Therapeutics closed Wednesday at $25.62. See how other analysts rate the stock.

Considering buying ASND stock? Here's what analysts think.